000027595 000__ 01474cam\a22004215i\4500
000027595 000__ 01773nam\a2200445Ia\4500
000027595 001__ 27595
000027595 003__ SzGeWIPO
000027595 005__ 20231106110832.0
000027595 008__ 020415s2002\\\\sz\\\\\\r\\\\u000\0\eng\d
000027595 020__ $$a9789280521788
000027595 020__ $$z9280521780
000027595 035__ $$a(wipo)(CD )02-0299
000027595 035__ $$a(OCoLC)1159934543
000027595 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000027595 041__ $$aeng
000027595 08204 $$a346.0486$$223
000027595 084__ $$aW F5 946 (3E) 2012
000027595 1102_ $$aWorld Intellectual Property Organization
000027595 24510 $$aPatent landscape report on Vaccines for selected infectious diseases.
000027595 264_1 $$aGeneva :$$bWorld Intellectual Property Organisation (WIPO),$$c[2002]
000027595 300__ $$a187 pages ;$$c30 cm.
000027595 336__ $$atext$$btxt$$2rdacontent
000027595 337__ $$aunmediated$$bn$$2rdamedia
000027595 338__ $$avolume$$bnc$$2rdacarrier
000027595 4901_ $$aWIPO Publication
000027595 500__ $$aWIPO Publication No. 946 (3E) 2012.
000027595 5050_ $$a1. Active ingredients of vaccines against infections diseases; 2. Active ingredients of human pneumococcal conjugate vaccines; 3. Active ingredients of human typhoid conjugate vaccines; 4. Active ingredient of human influenza vaccines.
000027595 650_0 $$aPharmaceutical biotechnology$$vPatents.
000027595 650_0 $$aVaccines$$xPatents.
000027595 650_0 $$aPatent laws and legislation.
000027595 650_0 $$aIntellectual property (International law)
000027595 650_0 $$aPatents.
000027595 7102_ $$aWorld Intellectual Property Organization,.
000027595 830_0 $$aWIPO Publication.
000027595 8564_ $$uhttp://www.wipo.int/edocs/pubdocs/en/patents/946/wipo_pub_946_3.pdf
000027595 903_0 $$aWIPO Publication
000027595 942__ $$cMON$$jW F5 946 (3E) 2012$$2ddc
000027595 952__ $$w2015-09-30$$p2015-0148$$u42109$$bMAIN$$10$$kW F5 946 (3E) 2012$$v2015-09-30$$zTagged$$70$$cLibrary
000027595 980__ $$aBIB
000027595 980__ $$aWIPOPUB$$aPLR
000027595 999__ $$c30038$$d30038